July 9, 2009

1 Min Read
Study: EGCG and Colon Cancer

GIFU, JapanIt's been previously reported that ()-epigallocatechin gallate (EGCG) in green tea alters plasma membrane organization and causes internalization of epidermal growth factor receptor (EGFR), resulting in the suppression of colon cancer cell growth. A recent study found the mechanism underlying EGCG-induced downregulation of EGFR colon cancer cells was due to phosphorylation of EGFR. (Carcinogenesis 2009) (DOI:10.1093/carcin/bgp166). Prolonged exposure to EGCG caused EGFR degradation. However, EGCG required neither an ubiquitin ligase (c-Cbl) binding to EGFR nor phosphorylation of EGFR at tyrosine residues, both of which are reportedly necessary for EGFR degradation induced by EGF. In addition, EGCG induced phosphorylation of p38 mitogen-activated protein kinase (MAPK), a stress-inducible kinase believed to negatively regulate tumorigenesis, and the inhibition of p38 MAPK by SB203580, a specific p38 MAPK inhibitor, or the gene silencing using p38 MAPK-siRNA suppressed the internalization and subsequent degradation of EGFR induced by EGCG. EGFR underwent a gel mobility shift upon treatment with EGCG and this was canceled by SB203580, indicating EGCG causes EGFR phosphorylation via p38 MAPK. EGCG caused phosphorylation of EGFR at Ser1046/1047, a site which is critical for its downregulation and this was also suppressed by SB203580 or siRNA of p38 MAPK.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like